Citadel Advisors
ANAC

Citadel Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Citadel Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20,400
Closed -$1.09M – 8060
2016
Q1 		$1.09M Buy
20,400
+1,900
+10% +$140K ﹤0.01% 3376
2015
Q4 		$2.09M Buy
18,500
+7,800
+73% +$859K ﹤0.01% 2690
2015
Q3 		$1.26M Sell
10,700
-31,500
-75% -$4.11M ﹤0.01% 3517
2015
Q2 		$3.27M Buy
42,200
+29,300
+227% +$1.92M ﹤0.01% 2498
2015
Q1 		$746K Sell
12,900
-2,500
-16% -$106K ﹤0.01% 4340
2014
Q4 		$497K Buy
15,400
+8,200
+114% +$246K ﹤0.01% 4735
2014
Q3 		$176K Buy
+7,200
New +$146K ﹤0.01% 5860
2014
Q2 		– Sell
-400
Closed -$8K – 8878
2014
Q1 		$8K Buy
+400
New +$7.76K ﹤0.01% 7593

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Citadel Advisors's ANAC Position: Q2 2016 in Review

Citadel Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 313,988 shares — an estimated $16.8M sold.

Citadel Advisors first reported a position in ANAC in Q1 2014 and held it in 8 quarters. The position peaked at $81M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Citadel Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Citadel Advisors sold 313,988 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $16.8M.
  • Citadel Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 8 quarters.
  • Citadel Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $81M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.